Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-13

Clinical Trial Update: Predicting Successful Sleep Apnea Treatment With Acetazolamide in Heart Failure Patients [NA]

View source ↗

Summary

The clinical trial evaluating acetazolamide to predict successful sleep apnea treatment in heart failure patients has completed and posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: David Andrew Wellman | Conditions: Heart Failures | NA | Status: COMPLETED | Results posted: 2018-06-13